Literature DB >> 22475780

Association between Val158Met functional polymorphism in the COMT gene and risk of preeclampsia in a Chinese population.

Shanshan Liang1, Xinghui Liu, Ping Fan, Rui Liu, Juan Zhang, Guolin He, Yu Liu, Huai Bai.   

Abstract

BACKGROUND AND AIMS: The catechol-O-methyltransferase (COMT) gene is a potential candidate in altering risk for preeclampsia due to the important enzymatic effects in the metabolism of steroid hormones. It contains a non-synonymous G-A base change at codon 158 in the membrane bound isoform, which leads to a valine-to-methionine amino acid substitution. In the soluble isoform the polymorphism rs4680 is located in codon 108. The variant allele is the Met (A) allele and the Val (G) allele is the wild type allele. Despite its previously reported association with preeclampsia in genotypes in three selected ethnic groups, further studies in other populations are required.
METHODS: We genotyped the Val158Met polymorphism in the COMT gene by polymerase chain reaction-restriction fragment length polymorphisms (PCR-RFLP) analysis in a Chinese population.
RESULTS: In the case-control study that included 187 patients with preeclampsia (cases) and 189 normal subjects (controls), the AA genotype and variant Met allele frequencies of Val158Met in the COMT gene were significantly higher in patients with preeclampsia than those in the control group (both p <0.05). The odds ratio for the risk of preeclampsia was 2.395 [95% confidence interval (CI): 1.061-5.408] in women homozygous for the variant COMT allele (χ(2) = 4.649, p = 0.031). Furthermore, it showed that obese women homozygous for the variant COMT allele (Met/Met) had higher diastolic blood pressure levels during pregnancy than wild-type homozygotes (Val/Val) (p = 0.034).
CONCLUSIONS: Our study provided evidence in favor of COMT being a candidate gene for conferring genetic susceptibility to preeclampsia in a South West Chinese population.
Copyright © 2012 IMSS. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22475780     DOI: 10.1016/j.arcmed.2012.03.002

Source DB:  PubMed          Journal:  Arch Med Res        ISSN: 0188-4409            Impact factor:   2.235


  6 in total

1.  Genetic variations in the vitamin-D receptor (VDR) gene in preeclampsia patients in the Chinese Han population.

Authors:  Ying Zhan; Mengchun Liu; Yuelan You; Yan Zhang; Jingli Wang; Xunfeng Wang; Shiguo Liu; Xuemei Liu
Journal:  Hypertens Res       Date:  2015-03-19       Impact factor: 3.872

Review 2.  Metabolic pathways involved in 2-methoxyestradiol synthesis and their role in preeclampsia.

Authors:  Alejandra Perez-Sepulveda; Pedro P España-Perrot; Errol R Norwitz; Sebastián E Illanes
Journal:  Reprod Sci       Date:  2013-03-01       Impact factor: 3.060

3.  2-methoxyestradiol plasma levels are associated with clinical severity indices and biomarkers of preeclampsia.

Authors:  Miriam Pertegal; Francisco J Fenoy; Barbara Bonacasa; Jaime Mendiola; Juan L Delgado; Moises Hernández; Miguel G Salom; Vicente Bosch; Isabel Hernández
Journal:  Reprod Sci       Date:  2014-06-04       Impact factor: 3.060

4.  Protective Role of Maternal P.VAL158MET Catechol-O-Methyltransferase Polymorphism against Early-Onset Preeclampsia and its Complications.

Authors:  Tijana Krnjeta; Ljiljana Mirković; Svetlana Ignjatović; Dragana Tomašević; Jelena Lukić; Drina Topalov; Ivan Soldatović; Nada Majkić-Singh
Journal:  J Med Biochem       Date:  2016-07-06       Impact factor: 3.402

5.  Catechol-O-methyltransferase and Pregnancy Outcome: an Appraisal in Rat.

Authors:  Khursheed Iqbal; Pramod Dhakal; Stephen H Pierce; Michael J Soares
Journal:  Reprod Sci       Date:  2020-10-13       Impact factor: 3.060

6.  Genetic variations in IL1A and IL1RN are associated with the risk of preeclampsia in Chinese Han population.

Authors:  Jing Li; Mengchun Liu; Jinbao Zong; Ping Tan; Jingli Wang; Xunfeng Wang; Yuanhua Ye; Shiguo Liu; Xuemei Liu
Journal:  Sci Rep       Date:  2014-06-11       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.